|
The alleged complaint could not be confirmed.This 59-year-old male patient was revised approximately 7 months after the primary operation due to an alleged infection.During the revision operation, the subject 14mm tibial insert, eis7s14r, was replaced with a 17mm tibial insert.The revised implant was not returned.Additionally, mpo has not received any clinical information to confirm the presence or source of infection.This lot was manufactured in 2022.Review of the device history record (dhr) for the subject lot indicates that this part met all established acceptance criteria throughout manufacturing processes, including all aspects related to cleaning and sterilization processes.Furthermore, review of historical complaint data confirms no other reported instances for the subject manufacturing lot, and no trends were identified for the other manufacturing lots from the same sterile batch.Infection is a known possible adverse effect of any surgical procedure and is captured within mpo risk management and relevant knee systems package insert.Conclusions regarding the source of infection or other possible contributing factors cannot be made for this case.Trend analysis reveals a large spike in complaints for infection involving this product family was captured during march 2025.The majority of these reports are from a german registry source without and product or lot identifying information or other details regarding each instance.There were not any trends identified for the known manufacturing lots for complaints in the trend period.Dfmea comparison shows no changes in occurrence level.Therefore, based on these investigation findings, additional trend analysis or other escalation is not deemed necessary at this time.Mpo will continue to be monitored through complaint tracking.
|